Qol Holdings Co.,Ltd. (3034) Cash flow
Market cap
¥72.9B
P/E ratio
9x
Cure All Holdings operates pharmacies, provides business outsourcing services to pharmaceutical companies, and manufactures drugs to support healthcare across communities.
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Depreciation & amortization | 1,611 | 1,607 | 1,584 | 1,624 | 1,718 | 1,649 | 1,580 | 1,565 | 1,680 | 1,848 | 4,031 | 5,592 |
| Cash from operations | 7,841 | 7,600 | 5,813 | 11,116 | 5,773 | 4,468 | 12,912 | 10,112 | 11,662 | 13,533 | 12,593 | 18,665 |
| Capital expenditures | -1,486 | -1,605 | -1,457 | -1,628 | -1,434 | -1,481 | -1,635 | -1,540 | -4,168 | -2,072 | -3,224 | -1,679 |
| Cash from investing | -5,066 | -3,409 | -15,392 | -3,775 | -8,287 | -8,670 | -3,065 | -3,087 | -7,013 | -13,155 | -20,360 | -9,088 |
| Payments for dividends | -597 | -755 | -896 | -878 | -1,088 | -1,075 | -1,058 | -1,055 | -1,092 | -1,205 | -1,206 | -1,504 |
| Repurchases of common stock | -1,413 | - | -2,838 | - | - | -1,499 | -1,877 | - | - | - | - | -232 |
| Proceeds from issuance of term debt, net | 10,392 | 680 | 11,125 | 7,000 | 13,000 | 14,000 | 9,143 | 6,100 | 9,000 | 18,300 | 5,000 | 7,800 |
| Repayments of term debt | -6,080 | -5,393 | -5,844 | -7,152 | -8,262 | -10,694 | -9,835 | -11,230 | -9,826 | -8,810 | -9,479 | -9,529 |
| Cash from financing | 278 | 4,085 | 7,435 | -1,685 | 2,906 | -225 | -6,114 | -10,006 | -2,569 | 7,969 | 7,201 | -14,966 |